المؤلفون: Fabi A. (11802869), Ciccarese M. (11802872), Scagnoli S. (11802875), Russillo M. (11802878), Schettini F. (11802881), Buono G. (11802884), Lorusso V. (11802887), Cannita K. (11802890), Arpino G. (11802893), Stani S. (11802896), Palleschi M. (11802899), Rossello R. (11802902), Sarobba G. (11802905), Fabbri A. (11802908), Giampaglia M. (11802911), Pellegrini P. (11802914), Adamo V. (11802917), Morelli F. (11802920), Barberi V. (11802923), Ferretti G. (11802926), Catania G. (3835213), Pisegna S. (11802929), Cognetti F. (11802932), Giannarelli D. (11797373)

مصطلحات موضوعية: Medicine

Relation: https://figshare.com/articles/dataset/Supplementary_Material_for_Post-Progression_Treatments_after_Palbociclib_plus_Endocrine_Therapy_in_HR_HER2_Metastatic_Breast_Cancer_Patients_What_Is_the_Better_Choice_/17134667

الاتاحة: https://doi.org/10.6084/m9.figshare.17134667.v1